BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Charles G. Mullighan(St. Jude Children's Research Hospital), James R. Downing(St. Jude Children's Research Hospital), Deborah L. White(ANZCHOG), Letha A. Phillips, Christopher B. Miller(St. Jude Children's Research Hospital), Timothy P. Hughes(Royal Adelaide Hospital), Ina Radtke(St. Jude Children's Research Hospital), Michelle M. Le Beau(University of Chicago), Jing Ma(St. Jude Children's Research Hospital), James Dalton, Mary V. Relling(St. Jude Children's Research Hospital), Sheila Shurtleff(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital)
Cited by 1,079
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
|Military Medical Research|2020|2.4k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k